DCGI allows Biophore India to manufacture coronavirus drug Favipiravir API
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read moreDetails
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read moreDetailsNew Delhi: Biocon said Wednesday that its medical device to treat COVID-19 patient has received approval from the Drugs Controller ...
Read moreDetails
By Aakar Patel As a democratic society, it is expected that India’s authorities follow the rule of law. This includes...
Read moreDetails
By Dilip Cherian Three hours is barely enough time for a working lunch in New Delhi. Yet when UAE President...
Read moreDetails
Invariably US President Donald Trump says one thing and means something completely different has, by now, become clear to the...
Read moreDetails
We are aware how, once the month of January gets over, the rest of the year flies past in the...
Read moreDetails